Trial Profile
Phase I trial of intravesicular mitomycin formulated with hyaluronidase in patients with bladder cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Aug 2011
Price :
$35
*
At a glance
- Drugs Mitomycin (Primary)
- Indications Bladder cancer
- Focus Adverse reactions
- 29 Mar 2006 New trial record.